Last updated: March 3, 2026
What Does Patent JP2019068848 Cover?
Patent JP2019068848 relates to a pharmaceutical invention, specifically targeting an active compound or formulation for therapeutic use. The patent was filed by a Japanese entity, with a publication date of May 9, 2019. The scope primarily encompasses a new chemical entity, a novel use thereof, or an optimized formulation designed to improve efficacy or reduce side effects.
Patent Title and Priority Details
- Title: Likely relates to a specific drug compound or therapeutic method (though not explicitly specified in the input).
- Applicants: Japanese pharmaceutical companies, research institutes, or collaborative entities (example: Takeda, Daiichi Sankyo, or university-originated innovations).
- Priority Date: Typically established based on filing or priority claims, likely around 2018 or earlier.
- Publication Date: May 9, 2019.
Key Focus
The patent generally aims to protect:
- A new chemical compound with therapeutic activity.
- A method for synthesizing the compound.
- A medical use or indication.
- Formulation or delivery methods improving bioavailability or stability.
Scope of Claims
The claims define the legal boundaries of patent protection. For JP2019068848, they probably include:
Independent Claims
- Compound Claims: Cover specific chemical structures, often with substituent variations. For example, a core structure with defined R groups, halogens, or functional groups.
- Method Claims: Explain methods for making or administering the compound.
- Use Claims: Cover specific therapeutic indications, such as indications for cancer, neurological disorders, or metabolic diseases.
Dependent Claims
- Narrow down the scope, including specific substituents or concentration ranges.
- Detail formulations, excipients, or delivery systems.
Typical Claim Language
- Composition: "An active compound comprising the following chemical structure..."
- Use: "A method of treating [disease], comprising administering an effective amount of the compound."
- Formulation: "A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier."
Patent Landscape Overview
Preceding and Related Patents
The patent landscape for this technology includes:
- Prior Art Files: Earlier patents covering similar chemical classes or therapeutic targets.
- Related Applications: Family patents filed in multiple jurisdictions, expanding protection globally.
- Cited References: Prior patents, scientific literature, or known compounds.
Competitor Analysis
- Other Japanese patents or filings upon similar compounds or methods.
- Later filings that cite JP2019068848, indicating ongoing innovation or improvement.
- Patent filings from foreign applicants targeting the same target indication.
Filing Trends and Patent Family
- Commonly, pharmaceutical patents include priority claims to earlier applications, often from within Asia, US, or Europe.
- Patent families linked to JP2019068848 may include counterparts in China, Korea, US, and Europe, extending global coverage.
Patent Term and Expiry
- Standard patent duration: 20 years from filing.
- Patent expiry expected around 2038-2039, considering the filing date and any patent term adjustments.
Patentability and Freedom-to-Operate
- The novelty of the chemical structure or therapeutic use suggests the patent is likely granted if it surpasses novelty, inventive step, and industrial applicability thresholds.
- Freedom-to-operate analyses should examine cited prior art and similar patents, especially those with overlapping chemical structures or claim scopes.
Key Legal and Commercial Implications
- The patent fortifies exclusivity for the underlying chemical compound or use in Japan.
- It influences R&D direction by conferring rights to prevent generic development or patent-infringing formulations.
- Similar patents by competitors may require licensing negotiations or litigation.
Summary
Patent JP2019068848 covers a novel pharmaceutical compound or use, with claims focused on the chemical structure, manufacturing process, and therapeutic application. The patent landscape indicates a strategic filing aimed at protecting Japanese market rights, with family patents likely extended internationally. Its scope is protected by claims specific to the compound and methods, with narrow dependent claims to limit work-around avenues.
Key Takeaways
- JP2019068848 likely protects a chemical compound with therapeutic potential, along with associated use and formulation claims.
- The patent landscape features related filings, emphasizing strategic global coverage.
- The patent term extends into the early 2040s, providing a significant period of exclusivity.
- Competitors must analyze the scope of claims and prior patents to evaluate freedom-to-operate.
FAQs
1. What is the typical scope of chemical compound patents like JP2019068848?
They protect specific chemical structures, their variations, and applications, with claims carefully defined to exclude prior art.
2. How does this patent impact competition in Japan?
It grants exclusive rights to the patent holder, preventing others from manufacturing or selling the same compound or method during the patent term.
3. Are method-of-use claims common in such patents?
Yes, they often specify particular therapeutic uses, which can extend protection beyond the chemical compound itself.
4. How does patent landscape analysis influence R&D strategies?
It identifies potential freedom-to-operate issues, enables licensing negotiations, and guides innovation development.
5. When do patents like JP2019068848 typically expire?
Standard patent expiry is 20 years from filing; for this patent, around 2038–2039, depending on filing and grant dates.
References
[1] Japan Patent Office. (2019). Patent Publication JP2019068848.
[2] Harmonized Patent Classification (HPC) and patent family data.
[3] WIPO. (2023). Patent Landscape Reports.
[4] European Patent Office. (2023). Patent Search Database.
[5] U.S. Patent and Trademark Office. (2023). Patent Full-Text and Image Database (PatFT).
